Royce & Associates LP Insmed Inc Transaction History
Royce & Associates LP
- $10.5 Billion
- Q3 2024
A detailed history of Royce & Associates LP transactions in Insmed Inc stock. As of the latest transaction made, Royce & Associates LP holds 95,027 shares of INSM stock, worth $6.71 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
95,027
Previous 95,027
-0.0%
Holding current value
$6.71 Million
Previous $6.37 Million
8.95%
% of portfolio
0.07%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding INSM
# of Institutions
466Shares Held
180MCall Options Held
2.27MPut Options Held
3.33M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.01 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$888 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$741 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$461 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.56B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...